| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
633,310,000 |
| Market
Cap: |
3.70(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$5.2865 - $9.615 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 790 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Hypera is a pharmaceutical company. Under the umbrella brand Mantecorp Farmasa; Co. operates in various medical areas within the Primary Care segment, including several products in Brazil, including Predsim, Celestamine, Maxsulid, Diprospan, Mioflex-A and Addera D3. Under the brand Mantecorp Skincare, it provides dermo-cosmetics recommended by dermatologists throughout Brazil. Co. is a supplier in the Brazilian market of prescription-free products, including brands such as Apracur, Benegrip, Coristina d, Engov, Epocler and Estomazil, among others. It also provides nutrition, sweeteners and vitamin supplement lines, with brands such as Tamarine, Vitasay 50+, Biotonico Fontoura and Zero-Cal.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
0.12 (1.93%) 
